Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | AGN | TEVA | MYL | RDY |
| Company | Zynerba Pharma CS | Allergan Plc | Teva Pharmaceutical Industries ADR | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 1.2600 | 193.01 | 12.94 | 15.64 | 71.47 |
| High | 1.3400 | 193.38 | 12.98 | 16.15 | 72.23 |
| Low | 1.2600 | 191.64 | 12.69 | 15.34 | 71.47 |
| Last | 1.3000 | 193.02 | 12.88 | 15.86 | 72.15 |
| Change | +0.0300 | +0.03 | +0.02 | +0.31 | +1.01 |
| % Change | +2.36% | +0.02% | +0.16% | +1.96% | +1.42% |
| Volume | 862,700 | 12,442,600 | 7,945,100 | 26,574,100 | 157,900 |
| 20-Day Average Volume | 1,093,995 | 4,993,145 | 8,984,740 | 8,612,350 | 164,455 |
| Previous Close | 1.2700 | 192.99 | 12.86 | 15.55 | 71.14 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | No | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 188.05 | 13.70 | 15.15 | 72.59 |
| 20-Day Raw Stochastic | 53.49% | 76.90% | 18.93% | 86.27% | 38.52% |
| 20-Day Relative Strength | 62.80% | 59.14% | 42.76% | 55.75% | 46.11% |
| Weighted Alpha | -35.90 | +28.20 | +52.63 | -23.10 | +17.78 |
| Today's Opinion | 80% Buy | 72% Buy | 56% Buy | 40% Sell | 40% Buy |
| Previous Opinion | 80% Buy | 56% Buy | 56% Buy | 64% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 100% Buy | 64% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +1.73% since 05/01/20 | -2.65% since 04/15/24 | +4.86% since 11/09/20 | +1.45% since 04/15/24 |
| Low | 1.1850 on 10/04/23 | 187.75 on 05/04/20 | 12.51 on 04/19/24 | 15.10 on 11/10/20 | 70.71 on 04/19/24 |
| High | 1.3400 on 10/10/23 | 196.45 on 05/06/20 | 13.29 on 04/17/24 | 16.15 on 11/16/20 | 72.23 on 04/22/24 |
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | +6.59% since 04/08/20 | -7.27% since 03/22/24 | +0.92% since 10/16/20 | -1.81% since 03/22/24 |
| Low | 1.1850 on 10/04/23 | 181.21 on 04/09/20 | 12.51 on 04/19/24 | 14.00 on 10/29/20 | 70.71 on 04/19/24 |
| High | 1.4000 on 09/15/23 | 196.45 on 05/06/20 | 14.47 on 04/08/24 | 16.15 on 11/16/20 | 74.44 on 04/01/24 |
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | -2.05% since 02/07/20 | +12.10% since 01/22/24 | -2.07% since 08/14/20 | +7.11% since 01/22/24 |
| Low | 0.2500 on 07/11/23 | 158.67 on 03/18/20 | 11.48 on 01/30/24 | 14.00 on 10/29/20 | 67.60 on 01/23/24 |
| High | 1.4000 on 09/15/23 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 17.03 on 08/19/20 | 77.72 on 02/23/24 |
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | +6.48% since 11/08/19 | +58.62% since 10/20/23 | +4.58% since 05/15/20 | +8.95% since 10/20/23 |
| Low | 0.2500 on 07/11/23 | 158.67 on 03/18/20 | 8.06 on 10/23/23 | 14.00 on 10/29/20 | 63.72 on 11/03/23 |
| High | 1.4000 on 09/15/23 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 19.24 on 06/08/20 | 77.72 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 63,503,972 | 14,439,691 | 8,586,212 | 12,040,249 |
| Shares Outstanding, K | 53,939 | 329,002 | 1,121,094 | 541,546 | 166,878 |
| Annual Sales | 0 | 16,088,900,000 | 15,846,000,000 | 11,500,500,000 | 2,992,000,000 |
| Annual Net Income | -35,040,000 | -5,271,000,000 | -559,000,000 | 16,800,000 | 548,000,000 |
| Last Quarter Sales | 0 | 4,351,000,000 | 4,457,000,000 | 2,972,100,000 | 865,780,000 |
| Last Quarter Net Income | -10,780,000 | -317,200,000 | 429,000,000 | 185,700,000 | 165,470,000 |
| 60-Month Beta | 1.32 | 1.20 | 1.05 | 1.45 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | 5.22 on 02/10/20 | 1.00 on 01/31/24 | 0.36 on 11/06/20 | 0.99 on 01/31/24 |
| Latest Earnings Date | 11/13/23 | 05/07/20 | 05/08/24 | 11/06/20 | 05/08/24 |
| Most Recent Dividend | N/A | 0.740 on 04/15/20 | 0.072 on 11/27/17 | 0.060 on 06/27/07 | 0.410 on 07/28/23 |
| Next Ex-Dividends Date | N/A | 04/15/20 | 11/27/17 | N/A | 07/28/23 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.94 | 5.21 | 3.29 | 18.77 |